Prescription drug · UNAPPROVED DRUG OTHER
Me NaPhos MB Hyo 1 (urinary antiseptic antispasmodic) NDC 58657-454
Methenamine 81.6 mg/1 + 3 more ingredients · Tablet · Oral · Method Pharmaceuticals
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 58657-454-01 | 58657045401 | 100 TABLET in 1 BOTTLE (58657-454-01)Marketed from Dec 1, 2015 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Me NaPhos MB Hyo 1
- Generic name (nonproprietary)
- urinary antiseptic antispasmodic
- Active ingredients
- Methenamine — 81.6 mg/1Sodium phosphate, Monobasic, Monohydrate — 40.8 mg/1Methylene blue anhydrous — 10.8 mg/1Hyoscyamine sulfate anhydrous — .12 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Method Pharmaceuticals
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Oxidation-Reduction Activity (Mechanism)
- Identifiers
- Product ID 58657-454_41b576a1-2a59-9f3c-e063-6394a90aec7dSPL ID 41b576a1-2a59-9f3c-e063-6394a90aec7dSPL set ID 2ae628e7-3b33-6a9a-e054-00144ff8d46cRxCUI 1050325UNII J50OIX95QV, 593YOG76RN, 8NAP7826UB, OB570Z127KUPC 0358657454012
- Pharmacologic class
- Oxidation-Reduction Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N458657045401followed by a unit qualifier and the quantityPackage 58657-0454-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATION AND USAGE ME/NaPhos/MB/Hyo 1 Tablets is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as hypermotility which accompany lower urinary tract infections and as antispasmodic. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Excerpt only. Read the full label for complete information.